Fiji vs South Korea: New cases tested for RR-/MDR-TB
Fiji
100.0%
in 2024
South Korea
100.0%
in 2024
Fiji rank
1st
South Korea rank
1st
New cases tested for RR-/MDR-TB over time
- Fiji
- South Korea
How they compare
Fiji currently reports 100.0% against 100.0% in South Korea, a difference of 0.0%.
The two have swapped places 2 times across 13 shared years of data; in 2011 it was South Korea ahead.
Fiji ranks 1st and South Korea ranks 1st of 192 countries.
South Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Fiji | South Korea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 58.2% | 78.6% | 20.4% | South Korea |
| 2020s | 79.2% | 94.2% | 15.0% | South Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Fiji or South Korea?
- Fiji, at 100.0% against 100.0% in South Korea as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Fiji and South Korea?
- 0.0%, with Fiji ahead.
- How many years of comparable data are there for Fiji and South Korea?
- 13 years are reported by both, from 2011 to 2024.
- How do Fiji and South Korea rank globally for new cases tested for rr-/mdr-tb?
- Fiji ranks 1st and South Korea ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.